Leaflet HIRUDOID gel 3mg / g

Indicated for: prevention and treatment of thromboembolism

Route of administration: cutaneous

Substance: heparinoid (anticoagulant)

ATC: C05BA01 (Cardiovascular system | Antivaricose therapy | Heparins or heparinoids for topical use)

Precautions:
Dose adjustment in renal impairment
Dose adjustment in renal impairment

Dose adjustment may be needed in kidney disease.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Additional monitoring
Additional monitoring

This medicine is subject to additional monitoring.

Breastfeeding warning
Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Bleeding risk
Bleeding risk

This medicine may increase the risk of bleeding.

Heparinoid is a compound used for the treatment of inflammation and conditions associated with blood clot formation, such as superficial thrombophlebitis. It works by reducing inflammation and preventing clot formation.

The medication is applied topically, as a gel or cream, as directed by a doctor. It is important not to apply it to open wounds or damaged skin.

Side effects may include local irritation, redness, or allergic reactions. In rare cases, severe hypersensitivity reactions may occur.

Heparinoid is not recommended for patients with hypersensitivity to this compound or severe coagulation disorders.

General data about HIRUDOID GEL 3mg / g

  • Substance: heparinoid
  • Date of latest medicines list: 01-07-2013
  • Product code: W01842001
  • Concentration: 3mg / g
  • Pharmaceutical form: gel
  • Quantity: 1
  • Product type: Original
  • Prescription status: OTC - Over the Counter = medicine that does not require a medical prescription.

Marketing authorisation

  • Manufacturer: STADA ARZNEIMITTEL AG - GERMANIA
  • Holder: STADA ARZNEIMITTEL AG - GERMANIA
  • Number: 9773/2017/01
  • Shelf life: 5 years-after packing for marketing;after the first opening-1 year

Pharmaceutical forms available for heparinoid